Delayed Type Hypersensitivity Reactions

Delayed type hypersensitivity (DTH) reactions are a critical aspect of the immune system's defense mechanisms. These reactions are characterized by a delayed response to antigen exposure, typically taking 24 to 72 hours to manifest. Understanding the nuances of DTH reactions is essential for healthcare professionals in diagnosing and managing various conditions that involve immune system dysfunction.

What Causes Delayed Type Hypersensitivity?

Delayed type hypersensitivity reactions are mediated by T-cells, a type of white blood cell that plays a pivotal role in the immune response. Unlike immediate hypersensitivity reactions, which are antibody-mediated, DTH reactions involve the activation of T-cells that recognize antigens presented by antigen-presenting cells such as macrophages and dendritic cells.

Upon re-exposure to the antigen, sensitized T-cells release cytokines, which recruit macrophages and other immune cells to the site of antigen exposure, leading to tissue inflammation and damage. Common causes of DTH reactions include infections, contact with certain chemicals, and chronic diseases such as tuberculosis and leprosy.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Symptoms of Delayed Type Hypersensitivity

The symptoms of DTH reactions can vary significantly based on the underlying cause and the area of the body affected. Common symptoms include:

Redness and Swelling: Due to increased blood flow and immune cell infiltration.
Induration: A localized hardening of soft tissue, often observed in skin tests.
Pain: Resulting from inflammation and pressure on surrounding tissues.
Itchiness: Common in contact dermatitis caused by allergens like poison ivy or nickel.

Examples of Delayed Type Hypersensitivity Reactions

Understanding the clinical presentation of DTH reactions can aid in the diagnosis and management of various conditions. Here are some examples:

Tuberculin Skin Test (TST): Used to diagnose tuberculosis, the TST involves injecting a purified protein derivative (PPD) under the skin. A positive result, indicated by induration and redness, signifies previous exposure to Mycobacterium tuberculosis.
Contact Dermatitis: This occurs when the skin comes into contact with allergens such as latex, nickel, or certain cosmetics. The immune response results in a rash and itching.
Granulomatous Inflammation: Seen in chronic infections like tuberculosis and sarcoidosis, granulomas form as a result of a prolonged DTH reaction.

Diagnosing Delayed Type Hypersensitivity

Accurate diagnosis of DTH reactions is crucial for effective management. The following diagnostic tools are commonly used:

Skin Testing

Skin tests are a primary method for diagnosing DTH reactions. The Mantoux test, or tuberculin skin test, is one of the most widely used tests. After the intradermal injection of PPD, the test site is observed 48 to 72 hours later for signs of induration and erythema, indicative of a DTH reaction.

Patch Testing

Patch tests are utilized to identify specific allergens causing contact dermatitis. Small amounts of potential allergens are applied to the skin under patches, and reactions are observed after 48 to 72 hours. This helps identify substances that trigger DTH reactions and guides avoidance strategies.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Management of Delayed Type Hypersensitivity Reactions

Managing DTH reactions involves a multifaceted approach, focusing on alleviating symptoms and addressing the underlying cause.

Symptomatic Treatment

Corticosteroids: Topical or systemic corticosteroids can reduce inflammation and alleviate symptoms such as itching and swelling.
Antihistamines: Although less effective for DTH reactions compared to immediate hypersensitivity reactions, they can help with itching.

Avoidance Strategies

Identifying and avoiding triggers is crucial in managing contact dermatitis. Patch testing can provide valuable information about specific allergens to avoid.

Addressing Underlying Conditions

For chronic DTH reactions caused by infections or autoimmune conditions, treating the underlying disease is paramount. For instance, anti-tuberculosis therapy is essential for managing DTH reactions in tuberculosis.

Treatment Innovations and Research

Recent advances in immunology have shed light on potential treatment strategies for DTH reactions. Biologics targeting specific cytokines involved in the DTH response are under investigation. These therapies aim to modulate the immune response more precisely, offering hope for patients with chronic conditions associated with DTH reactions.

Additionally, research is ongoing to develop vaccines that can modulate T-cell responses, potentially preventing or reducing the severity of DTH reactions in susceptible individuals.

Find Our Specialists

Book Doctor Appointment